VANCOUVER, British Columbia--(BUSINESS WIRE)--The University of British Columbia (UBC) and the Centre for Drug Research and Development (CDRD) today announced that Covidien, a leading global provider of healthcare products, has licensed an innovative drug-delivery platform technology invented by UBC researcher, Pieter Cullis. This transaction represents the first successful licensing agreement of a technology jointly developed between a UBC researcher and the full drug development platform available at CDRD.
